BAYER CROPSCIENCE NV

Their core work

Bayer CropScience NV is the Belgian subsidiary of Bayer AG's global crop science division — one of the world's largest agrochemical and seed companies. In H2020, they participated as an industry partner in Marie Skłodowska-Curie research networks, hosting academic researchers and contributing commercial plant breeding expertise to projects on thermotolerant wheat and the genetic control of meiotic recombination in crops. Their value in these consortia is bridging fundamental plant genetics research with large-scale industrial crop development pipelines, where traits like heat stress tolerance and controlled recombination have direct commercial relevance. They do not lead public research projects — their role is to anchor academic work to real breeding programs and market pathways.

What they specialise in

How they've shifted over time

Their H2020 activity spans only 2016–2022, so the evolution window is narrow, but there is a clear directional shift. The earlier project, HEAT-WHEAT, addressed an applied challenge — engineering thermotolerance into a specific crop (wheat) under climate pressure. The later project, MEICOM, moved toward more fundamental plant genetics: meiosis, recombination, epigenome, and genome targeting across multiple crop species including brassicas, tomato, barley, and maize. This suggests a trajectory from single-crop applied research toward platform-level genetic tools applicable across the full crop portfolio. The breadth of crop species in MEICOM's keywords (7 species) compared to HEAT-WHEAT's single-crop focus reinforces this widening scope.

Bayer CropScience is moving toward fundamental genetic control mechanisms — particularly recombination and epigenome editing — that would underpin next-generation precision breeding across their entire crop portfolio, not just single-trait improvements.

How they like to work

Bayer CropScience NV has never led an H2020 project — they join as participant or third party, consistently in a supporting industry role. Their participation in MSCA schemes (training networks and individual fellowships) indicates they primarily contribute by hosting researchers within their commercial breeding infrastructure rather than driving scientific agendas. With 19 unique partners across just 2 projects, they work in medium-to-large multi-institutional consortia typical of MSCA training networks, where a mix of universities and industry partners share supervision responsibilities.

19 unique consortium partners across 7 countries from only 2 projects — a relatively broad network for a limited H2020 footprint, reflecting the multi-partner structure typical of MSCA Innovative Training Networks. Their connections likely span major European plant science research universities and public breeding institutes.

What sets them apart

Bayer CropScience brings something most consortium partners cannot: direct access to large-scale industrial crop breeding pipelines and commercial germplasm collections across wheat, barley, maize, brassicas, and tomato. Partnering with them means research results have a credible path to field application, which strengthens both scientific impact claims and the practical relevance of grant proposals. As the industry anchor in academic-led MSCA consortia, they also provide researchers with real-world constraints and data that purely academic partners cannot replicate.

Highlights from their portfolio

• HEAT-WHEAT
  Their only directly funded H2020 project (EUR 165,600), addressing thermotolerant wheat — a commercially critical climate-adaptation challenge for one of the world's most important staple crops.
• MEICOM
  A broad MSCA Innovative Training Network covering meiotic recombination across 7 crop species, where Bayer's participation as an industry host signals the commercial relevance of recombination control to precision plant breeding.